DrugPatentWatch Database Preview
ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER Drug Profile
Which patents cover Esmolol Hydrochloride Double Strength In Plastic Container, and when can generic versions of Esmolol Hydrochloride Double Strength In Plastic Container launch?
Esmolol Hydrochloride Double Strength In Plastic Container is a drug marketed by Hq Spclt Pharma and is included in one NDA. There are four patents protecting this drug.
This drug has forty-three patent family members in twenty-five countries.
The generic ingredient in ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER is esmolol hydrochloride. There are eight drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the esmolol hydrochloride profile page.
Summary for ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER
| International Patents: | 43 |
| US Patents: | 4 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Clinical Trials: | 78 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER |
| DailyMed Link: | ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Ain Shams University | Phase 4 |
| Ain Shams University | Phase 3 |
| Beni-Suef University | Phase 1/Phase 2 |
See all ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER clinical trials
Recent Litigation for ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER
Identify potential future generic entrants
District Court Litigation
| Case Name | Date |
|---|---|
| BAXTER HEALTHCARE CORPORATION v. AGILA SPECIALTIES PRIVATE LIMITED | 2014-11-12 |
| BAXTER HEALTHCARE CORPORATION v. HQ SPECIALTY PHARMA CORPORATION | 2013-10-18 |
| BAXTER HEALTHCARE CORPORATION v. AGILA SPECIALTIES PRIVATE LIMITED |
See all ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER litigation
PTAB Litigation
| Petitioner | Date |
|---|---|
| Mylan Pharmaceuticals Inc. | 2015-11-19 |
See all ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER litigation
Pharmacology for ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER
| Drug Class | beta-Adrenergic Blocker |
| Mechanism of Action | Adrenergic beta-Antagonists |
US Patents and Regulatory Information for ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER
International Patents for ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 1368019 | Start Trial |
| Japan | 2004519506 | Start Trial |
| Denmark | 1368019 | Start Trial |
| Austria | 341319 | Start Trial |
| South Africa | 200206688 | Start Trial |
| China | 1455669 | Start Trial |
| Russian Federation | 2002132189 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
